Arne Mork

Copenhagen, 2500, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Advancements in NMDA Receptor-Targeted Antidepressants: From d-Cycloserine Discovery to Preclinical Efficacy of Lu AF90103.

Advancements in NMDA Receptor-Targeted Antidepressants: From d-Cycloserine Discovery to Preclinical Efficacy of Lu AF90103.

Journal: Journal of medicinal chemistry

Published: November 19, 2024

Combined In Vivo Microdialysis and PET Studies to Validate [11C]Yohimbine Binding as a Marker of Noradrenaline Release.

Combined In Vivo Microdialysis and PET Studies to Validate [11C]Yohimbine Binding as a Marker of Noradrenaline Release.

Journal: Biomolecules

Published: March 12, 2023

Reduced Brd1 expression leads to reversible depression-like behaviors and gene-expression changes in female mice.

Reduced Brd1 expression leads to reversible depression-like behaviors and gene-expression changes in female mice.

Journal: Translational psychiatry

Published: February 03, 2020

The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.

The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.

Journal: Nature communications

Published: February 20, 2019

A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission.

A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission.

Journal: Translational psychiatry

Published: April 04, 2017

Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat.

Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat.

Journal: Neuropharmacology

Published: March 13, 2017

Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease.

Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease.

Journal: Neuropharmacology

Published: January 19, 2017

Effects of the 5-HT6 receptor antagonist idalopirdine on extracellular levels of monoamines, glutamate and acetylcholine in the rat medial prefrontal cortex.

Effects of the 5-HT6 receptor antagonist idalopirdine on extracellular levels of monoamines, glutamate and acetylcholine in the rat medial prefrontal cortex.

Journal: European journal of pharmacology

Published: October 13, 2016

Selegiline induces a wake promoting effect in rats which is related to formation of its active metabolites.

Selegiline induces a wake promoting effect in rats which is related to formation of its active metabolites.

Journal: Pharmacology, biochemistry, and behavior

Published: August 22, 2016

Involvement of presynaptic 5-HT1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats.

Involvement of presynaptic 5-HT1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats.

Journal: Pharmacology, biochemistry, and behavior

Published: July 08, 2016

Task- and Treatment Length-Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats.

Task- and Treatment Length-Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats.

Journal: The Journal of pharmacology and experimental therapeutics

Published: March 25, 2016

The Schizophrenia-Associated BRD1 Gene Regulates Behavior, Neurotransmission, and Expression of Schizophrenia Risk Enriched Gene Sets in Mice.

The Schizophrenia-Associated BRD1 Gene Regulates Behavior, Neurotransmission, and Expression of Schizophrenia Risk Enriched Gene Sets in Mice.

Journal: Biological psychiatry

Published: February 05, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026